Phase 1b study of the safety and antitumour activity of durvalumab (MEDI4736) + tremelimumab in advanced NSCLC Meeting Abstract
| Authors: | Rizvi, N.; Balmanoukian, A.; Goldberg, S. B.; Chaft, J.; Sanborn, R. E.; Rebelatto, M. C.; Narwal, R.; Robbins, P. B.; Gu, Y.; Karakunnel, J. J.; Antonia, S. |
| Abstract Title: | Phase 1b study of the safety and antitumour activity of durvalumab (MEDI4736) + tremelimumab in advanced NSCLC |
| Meeting Title: | ESMO Asia 2015 Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 26 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2015 Dec 18-21 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2015-12-01 |
| Start Page: | ix126 |
| Language: | English |
| ACCESSION: | WOS:000367158700417 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdv532.02 |
| Notes: | Meeting Abstract: 418O -- Source: Wos |
